GSK and Cambridge University announce new five-year collaboration in kidney and respiratory disease. GSK is investing more than £50 million in the CG-TIC to ... GSK announces positive... · GSK and Cambridge... · GSK receives US FDA...

Press releases · GSK Celebrates 2024 IMPACT Award Winners · GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. · New ...

Latest press releases, media assets and global media contacts. Press release archive. Annual Report 2023 (PDF - 8.3MB)

GSK today announced that the US CDC ACIP voted in favour of recommending the routine use of RSV vaccines in all adults aged 75 and above. Download (PDF ...

GSK today announced the launch of its new multichannel campaign 'Ab India Banega 7-Star.' 17 May 2024. GlaxoSmithKline Pharmaceutical Limited Reports Strong ...

Press releases. Browse Canadian-specific press ... GSK today announced that Health Canada granted full approval for Jemperli (dostarlimab for injection).

PHILADELPHIA, July 11, 2024--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare ...

Press releases · 08 October 2024. New report: Investment in adult vaccination can deliver a $1.1bn net annual return · 22 September 2024. More Australians to have ...

GSK ANNOUNCES SETTLEMENT BETWEEN ViiV HEALTHCARE AND GILEAD SCIENCES, INC. RESOLVING LITIGATION RELATING TO BIKTARVY AND ViiV'S DOLUTEGRAVIR PATENTS AND ENTRY ...

New Data for AREXVY, GSK's Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease.